SUBSCRIBE
SUBSCRIBE
News   FDA

Zeltia Group Shares Soar After Cancer Drug Approval

July 20, 2007 | 
1 min read
MADRID, July 20 (Reuters) - Shares in Spanish drug company Zeltia (ZEL.MC: Quote, Profile, Research) soared on Friday after its cancer treatment Yondelis was recommended for approval in Europe, its first medicine to make its way to the market.
FDA Approvals Europe
MORE ON THIS TOPIC
Contemporary art collage. Giang hand kicking office worker symbolizing dismissal. Unsuccessful employee. Job reduction. Concept of business, career, failure, success, troubles
Rare diseases
Ultragenyx Takes Second Hit as FDA Rejects Gene Therapy for Sanfilippo Syndrome
July 14, 2025
 · 
2 min read
 · 
Tristan Manalac
Regulatory
FDA Mulls Speedier Reviews to Companies Willing To Lower Drug Costs
July 14, 2025
 · 
1 min read
 · 
Tristan Manalac
Contemporary art collage showing a hand giving a thumbs down surrounded by red arrows pointing down, concept of negative feedback and bad review
Complete response letters
Capricor Plunges on FDA Rejection of DMD Cell Therapy
July 11, 2025
 · 
3 min read
 · 
Tristan Manalac
Cambridge, USA - 16 August 2024. View of Moderna office entrance with logo sign, Biotechnology industry
COVID-19
Moderna Wins Full Approval for COVID-19 Shot for Higher-Risk Kids
July 11, 2025
 · 
2 min read
 · 
Tristan Manalac